Chief Executive Officer

Chief Financial Officer

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing

GeneDx granted breakthrough device designation for whole genome, exome tests

GeneDx initiated with bullish view at Canaccord, here's why

People in the News at Nanopath, Proteomics International, Insight Molecular Diagnostics, GeneDx, More

Growth Lead, NICU

GeneDx is a leader in personalized health insights and genomic testing, and they are seeking a Growth Lead to drive the utilization of their products within the neonatal intensive care unit (NICU). This role involves evolving commercial strategy, enhancing customer engagement, and ensuring market leadership in the NICU segment.

Sign up with Google

Sign in with Google